<i>In vivo</i> Effects of Disease-modifying Therapies on Immunological Subsets in Patients with Relapsing-Remitting Multiple Sclerosis
DMTs induced significant modifications in B- and T-cell compartments. Characterizing these immunologic changes could deepen our understanding of the mechanisms of action of different therapies.
Authors
- Alessandra Romano (ORCID: https://orcid.org/0000-0002-6333-4433)
- Anna Maria Corsale (ORCID: https://orcid.org/0000-0002-2541-4619)
- Clara Grazia Chisari (ORCID: https://orcid.org/0000-0003-1607-543X)
- Sara Marino (ORCID: https://orcid.org/0000-0003-1332-5608)
- Giuseppe A. Palumbo (ORCID: https://orcid.org/0000-0003-1859-6319)
- Emanuele D’Amico (ORCID: https://orcid.org/0000-0001-7494-9057)
- Nunziatina Laura Parrinello (ORCID: https://orcid.org/0000-0002-9978-2908)
- Francesco Patti (ORCID: https://orcid.org/0000-0002-6923-0846)
- Chiara Finocchiaro (ORCID: https://orcid.org/0000-0002-1944-9540)
- Salvatore Lo Fermo
- Mario Zappia (ORCID: https://orcid.org/0000-0002-0393-4736)
- Francesco Di Raimondo
Institutions
- University of Foggia (IT)
- University of Catania (IT)
- Associazione Italiana Sclerosi Multipla (IT)
- Policlinico Universitario di Catania (IT)
- University of Palermo (IT)
Publication Details
- Journal
- Current Neuropharmacology
- Published
- 2025-07-05
- DOI
- https://doi.org/10.2174/011570159x360729250319064959
- Primary Topic
- Multiple Sclerosis Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00